Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Homozygous frame shift variant in ATP7B exon 1 leads to bypass of nonsense-mediated mRNA decay and to a protein capable of copper export.

Stalke A, Pfister ED, Baumann U, Eilers M, Schäffer V, Illig T, Auber B, Schlegelberger B, Brackmann R, Prokisch H, Krooss S, Bohne J, Skawran B.

Eur J Hum Genet. 2019 Jun;27(6):879-887. doi: 10.1038/s41431-019-0345-1. Epub 2019 Feb 5.

PMID:
30723317
2.

Effect of TP53 contact and conformational mutations on cell survival and erythropoiesis of human hematopoietic stem cells in a long term culture model.

Salari A, Thomay K, Lentes J, Ebersold J, Hagedorn M, Skawran B, Davenport C, Schambach A, Schlegelberger B, Göhring G.

Oncotarget. 2018 Jul 6;9(52):29869-29876. doi: 10.18632/oncotarget.25581. eCollection 2018 Jul 6.

3.

Diagnosis of monogenic liver diseases in childhood by next-generation sequencing.

Stalke A, Skawran B, Auber B, Illig T, Schlegelberger B, Junge N, Goldschmidt I, Leiskau C, von Neuhoff N, Baumann U, Pfister ED.

Clin Genet. 2018 Mar;93(3):665-670. doi: 10.1111/cge.13120. Epub 2017 Dec 12.

PMID:
28776642
4.

hsa-mir-183 is frequently methylated and related to poor survival in human hepatocellular carcinoma.

Anwar SL, Krech T, Hasemeier B, Schipper E, Schweitzer N, Vogel A, Kreipe H, Buurman R, Skawran B, Lehmann U.

World J Gastroenterol. 2017 Mar 7;23(9):1568-1575. doi: 10.3748/wjg.v23.i9.1568.

5.

The microRNA-449 family inhibits TGF-β-mediated liver cancer cell migration by targeting SOX4.

Sandbothe M, Buurman R, Reich N, Greiwe L, Vajen B, Gürlevik E, Schäffer V, Eilers M, Kühnel F, Vaquero A, Longerich T, Roessler S, Schirmacher P, Manns MP, Illig T, Schlegelberger B, Skawran B.

J Hepatol. 2017 May;66(5):1012-1021. doi: 10.1016/j.jhep.2017.01.004. Epub 2017 Jan 11.

PMID:
28088579
6.

HDAC inhibition activates the apoptosome via Apaf1 upregulation in hepatocellular carcinoma.

Buurman R, Sandbothe M, Schlegelberger B, Skawran B.

Eur J Med Res. 2016 Jun 24;21(1):26. doi: 10.1186/s40001-016-0217-x.

7.

Interferon-Mediated Cytokine Induction Determines Sustained Virus Control in Chronic Hepatitis C Virus Infection.

Wandrer F, Falk CS, John K, Skawran B, Manns MP, Schulze-Osthoff K, Bantel H.

J Infect Dis. 2016 Mar 1;213(5):746-54. doi: 10.1093/infdis/jiv505. Epub 2015 Oct 26.

PMID:
26503984
8.

The heteromeric transcription factor GABP activates the ITGAM/CD11b promoter and induces myeloid differentiation.

Ripperger T, Manukjan G, Meyer J, Wolter S, Schambach A, Bohne J, Modlich U, Li Z, Skawran B, Schlegelberger B, Steinemann D.

Biochim Biophys Acta. 2015 Sep;1849(9):1145-54. doi: 10.1016/j.bbagrm.2015.07.005. Epub 2015 Jul 11.

PMID:
26170143
9.

Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) is an important protumorigenic factor in hepatocellular carcinoma.

Gutschner T, Hämmerle M, Pazaitis N, Bley N, Fiskin E, Uckelmann H, Heim A, Groβ M, Hofmann N, Geffers R, Skawran B, Longerich T, Breuhahn K, Schirmacher P, Mühleck B, Hüttelmaier S, Diederichs S.

Hepatology. 2014 May;59(5):1900-11. doi: 10.1002/hep.26997. Epub 2014 Apr 1.

PMID:
24395596
10.

1,25-Dihydroxyvitamin D decreases HTRA1 promoter activity in the rhesus monkey--a plausible explanation for the influence of vitamin D on age-related macular degeneration?

Pahl L, Schubert S, Skawran B, Sandbothe M, Schmidtke J, Stuhrmann M.

Exp Eye Res. 2013 Nov;116:234-9. doi: 10.1016/j.exer.2013.09.012. Epub 2013 Sep 27.

PMID:
24076413
11.

Posttranscriptional destabilization of the liver-specific long noncoding RNA HULC by the IGF2 mRNA-binding protein 1 (IGF2BP1).

Hämmerle M, Gutschner T, Uckelmann H, Ozgur S, Fiskin E, Gross M, Skawran B, Geffers R, Longerich T, Breuhahn K, Schirmacher P, Stoecklin G, Diederichs S.

Hepatology. 2013 Nov;58(5):1703-12. doi: 10.1002/hep.26537. Epub 2013 Aug 7.

PMID:
23728852
12.

Histone methyltransferase Suv39h1 deficiency prevents Myc-induced chromosomal instability in murine myeloid leukemias.

Vajen B, Modlich U, Schienke A, Wolf S, Skawran B, Hofmann W, Büsche G, Kreipe H, Baum C, Santos-Barriopedro I, Vaquero A, Schlegelberger B, Rudolph C.

Genes Chromosomes Cancer. 2013 Apr;52(4):423-30. doi: 10.1002/gcc.22040. Epub 2013 Jan 23.

PMID:
23340989
13.

Histone deacetylases activate hepatocyte growth factor signaling by repressing microRNA-449 in hepatocellular carcinoma cells.

Buurman R, Gürlevik E, Schäffer V, Eilers M, Sandbothe M, Kreipe H, Wilkens L, Schlegelberger B, Kühnel F, Skawran B.

Gastroenterology. 2012 Sep;143(3):811-820.e15. doi: 10.1053/j.gastro.2012.05.033. Epub 2012 May 26.

PMID:
22641068
14.

Lentiviral vector induced insertional haploinsufficiency of Ebf1 causes murine leukemia.

Heckl D, Schwarzer A, Haemmerle R, Steinemann D, Rudolph C, Skawran B, Knoess S, Krause J, Li Z, Schlegelberger B, Baum C, Modlich U.

Mol Ther. 2012 Jun;20(6):1187-95. doi: 10.1038/mt.2012.59. Epub 2012 Apr 3.

15.

Human BRCA1-associated breast cancer: no increase in numerical chromosomal instability compared to sporadic tumors.

Focken T, Steinemann D, Skawran B, Hofmann W, Ahrens P, Arnold N, Kroll P, Kreipe H, Schlegelberger B, Gadzicki D.

Cytogenet Genome Res. 2011;135(2):84-92. doi: 10.1159/000332005. Epub 2011 Oct 24.

PMID:
22024613
16.

Neurogenic transdifferentiation of human adipose-derived stem cells? A critical protocol reevaluation with special emphasis on cell proliferation and cell cycle alterations.

Kompisch KM, Lange C, Steinemann D, Skawran B, Schlegelberger B, Müller R, Schumacher U.

Histochem Cell Biol. 2010 Nov;134(5):453-68. doi: 10.1007/s00418-010-0740-8. Epub 2010 Oct 13.

PMID:
20945072
17.

Analysis of array-CGH data using the R and Bioconductor software suite.

Hofmann WA, Weigmann A, Tauscher M, Skawran B, Focken T, Buurman R, Wingen LU, Schlegelberger B, Steinemann D.

Comp Funct Genomics. 2009:201325. doi: 10.1155/2009/201325. Epub 2009 Aug 19.

18.

Bronchial epithelial cells as a new source for differential transcriptome analysis after lung transplantation.

Skawran B, Dierich M, Steinemann D, Hohlfeld J, Haverich A, Schlegelberger B, Welte T, von Neuhoff N.

Eur J Cardiothorac Surg. 2009 Oct;36(4):715-21. doi: 10.1016/j.ejcts.2009.04.031. Epub 2009 Jun 13.

PMID:
19525122
19.

Losses of chromosome arms 4q, 8p, 13q and gain of 8q are correlated with increasing chromosomal instability in hepatocellular carcinoma.

Hertz S, Rothämel T, Skawran B, Giere C, Steinemann D, Flemming P, Becker T, Flik J, Wiese B, Soudah B, Kreipe H, Schlegelberger B, Wilkens L.

Pathobiology. 2008;75(5):312-22. doi: 10.1159/000151712. Epub 2008 Oct 15.

20.

Loss of 13q is associated with genes involved in cell cycle and proliferation in dedifferentiated hepatocellular carcinoma.

Skawran B, Steinemann D, Becker T, Buurman R, Flik J, Wiese B, Flemming P, Kreipe H, Schlegelberger B, Wilkens L.

Mod Pathol. 2008 Dec;21(12):1479-89. doi: 10.1038/modpathol.2008.147. Epub 2008 Sep 26.

21.

The differentiation/retrodifferentiation program of human U937 leukemia cells is accompanied by changes of VCP/p97.

Bertram C, von Neuhoff N, Skawran B, Steinemann D, Schlegelberger B, Hass R.

BMC Cell Biol. 2008 Feb 15;9:12. doi: 10.1186/1471-2121-9-12.

22.

Gene expression profiling in hepatocellular carcinoma: upregulation of genes in amplified chromosome regions.

Skawran B, Steinemann D, Weigmann A, Flemming P, Becker T, Flik J, Kreipe H, Schlegelberger B, Wilkens L.

Mod Pathol. 2008 May;21(5):505-16. doi: 10.1038/modpathol.3800998. Epub 2008 Feb 15.

23.

Promoter methylation of PARG1, a novel candidate tumor suppressor gene in mantle-cell lymphomas.

Ripperger T, von Neuhoff N, Kamphues K, Emura M, Lehmann U, Tauscher M, Schraders M, Groenen P, Skawran B, Rudolph C, Callet-Bauchu E, van Krieken JH, Schlegelberger B, Steinemann D.

Haematologica. 2007 Apr;92(4):460-8.

24.

Assessment of differentiation and progression of hepatic tumors using array-based comparative genomic hybridization.

Steinemann D, Skawran B, Becker T, Tauscher M, Weigmann A, Wingen L, Tauscher S, Hinrichsen T, Hertz S, Flemming P, Flik J, Wiese B, Kreipe H, Lichter P, Schlegelberger B, Wilkens L.

Clin Gastroenterol Hepatol. 2006 Oct;4(10):1283-91. Epub 2006 Sep 18.

PMID:
16979954
25.

Characterization of a human TSPY promoter.

Skawran B, Schubert S, Dechend F, Vervoorts J, Nayernia K, Lüscher B, Schmidtke J.

Mol Cell Biochem. 2005 Aug;276(1-2):159-67.

PMID:
16132697
26.

Generation and characterization of a transgenic mouse with a functional human TSPY.

Schubert S, Skawran B, Dechend F, Nayernia K, Meinhardt A, Nanda I, Schmid M, Engel W, Schmidtke J.

Biol Reprod. 2003 Sep;69(3):968-75. Epub 2003 May 28.

PMID:
12773407
27.

Spectrum of ATM gene mutations in a hospital-based series of unselected breast cancer patients.

Dörk T, Bendix R, Bremer M, Rades D, Klöpper K, Nicke M, Skawran B, Hector A, Yamini P, Steinmann D, Weise S, Stuhrmann M, Karstens JH.

Cancer Res. 2001 Oct 15;61(20):7608-15.

28.

Mutations of the BRCA1 and BRCA2 genes in patients with bilateral breast cancer.

Steinmann D, Bremer M, Rades D, Skawran B, Siebrands C, Karstens JH, Dörk T.

Br J Cancer. 2001 Sep 14;85(6):850-8.

29.

Molecular evolution of the murine tspy genes.

Schubert S, Dechend F, Skawran B, Krawczak M, Schmidtke J.

Cytogenet Cell Genet. 2000;91(1-4):239-42.

PMID:
11173864
30.

TSPY variants in six loci on the human Y chromosome.

Dechend F, Williams G, Skawran B, Schubert S, Krawczak M, Tyler-Smith C, Schmidtke J.

Cytogenet Cell Genet. 2000;91(1-4):67-71.

PMID:
11173833
31.

Silencing of the Y-chromosomal gene tspy during murine evolution.

Schubert S, Dechend F, Skawran B, Kunze B, Winking H, Weile C, Römer I, Hemberger M, Fundele R, Sharma T, Schmidtke J.

Mamm Genome. 2000 Apr;11(4):288-91.

PMID:
10754104
32.

BRCA1 expression is not affected by the intronic 12 bp duplication.

Dörk T, Skawran B, Stuhrmann M, Bremer M, Karstens JH.

J Med Genet. 1999 Mar;36(3):262-3. No abstract available.

33.

Frequency of BRCA1 mutation 5382insC in German breast cancer patients.

Backe J, Hofferbert S, Skawran B, Dörk T, Stuhrmann M, Karstens JH, Untch M, Meindl A, Burgemeister R, Chang-Claude J, Weber BH.

Gynecol Oncol. 1999 Mar;72(3):402-6.

PMID:
10053113
34.

Characterization of ATM gene mutations in 66 ataxia telangiectasia families.

Sandoval N, Platzer M, Rosenthal A, Dörk T, Bendix R, Skawran B, Stuhrmann M, Wegner RD, Sperling K, Banin S, Shiloh Y, Baumer A, Bernthaler U, Sennefelder H, Brohm M, Weber BH, Schindler D.

Hum Mol Genet. 1999 Jan;8(1):69-79.

PMID:
9887333
35.

Detection of 100% of the CFTR mutations in 63 CF families from Tyrol.

Stuhrmann M, Dörk T, Frühwirth M, Golla A, Skawran B, Antonin W, Ebhardt M, Loos A, Ellemunter H, Schmidtke J.

Clin Genet. 1997 Oct;52(4):240-6.

PMID:
9383031

Supplemental Content

Loading ...
Support Center